Vitamin C reduces cholesterol-induced microcirculatory changes in rabbits.
The microcirculation was studied for 10 weeks in untreated rabbits (n = 12) and in rabbits treated with vitamin C in their drinking water (0.5 g/d; n = 6), a 1% cholesterol diet (n = 12), or a combination of the two treatments (n = 11). The studies were performed by direct intravital microscopic imaging of the conjunctiva of both eyes to evaluate blood flow velocity, microvessel diameter, and microhemorheologic conditions. As we reported previously, changes occurred in all of the aforementioned variables as a consequence of cholesterol feeding. After 3 and 6 weeks of feeding, there was a marked and significant (P < .0001) decrease in blood flow velocity in third-order arterioles, which was accompanied by stasis and erythrocyte aggregation in the smaller conjunctival vessels. When cholesterol treatment was combined with vitamin C, blood flow was almost identical to that of controls and significantly (P < .0001) higher than that of rabbits treated with cholesterol alone. All other changes were also significantly reduced by the addition of vitamin C treatment to the cholesterol diet. Cholesterol-treated rabbits developed macroscopic arterial lesions that were not significantly reduced by vitamin C treatment. Neither circulating oxysterol levels nor atheromas were reduced by vitamin C treatment, which also had no significant effect on lipid or circulating vitamin E levels. We have previously shown that the lipid-soluble antioxidant BHT is able to prevent both cholesterol-induced microcirculatory changes and the development of arterial lesions in rabbits. This phenomenon is compatible with a critical oxidation step occurring in the lipid phase that is common to both processes. The finding that microcirculatory changes can be prevented by a water-soluble antioxidant is compatible with a role for water-soluble oxidants in this context. The possibility is discussed that vitamin C might also be important for the microcirculation in humans.
Freyschuss
A
A
Department of Medicine, Karolinska Institute, Huddinge University Hospital, Sweden.
Xiu
R J
RJ
Zhang
J
J
Ying
X
X
Diczfalusy
U
U
Jogestrand
T
T
Henriksson
P
P
Björkhem
I
I
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology* / Q000473:pathology; D001205:Ascorbic Acid / Q000494:pharmacology*; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism / Q000494:pharmacology*; D003228:Conjunctiva / Q000098:blood supply; D004036:Diet, Atherogenic; D004903:Erythrocyte Aggregation / Q000187:drug effects; D008297:Male; D008833:Microcirculation / Q000187:drug effects*; D010084:Oxidation-Reduction; D011817:Rabbits
D002784:Cholesterol; D001205:Ascorbic Acid